Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

0.83USD
4:47pm GMT
Change (% chg)

$0.04 (+4.80%)
Prev Close
$0.79
Open
$0.80
Day's High
$0.83
Day's Low
$0.80
Volume
1,035
Avg. Vol
24,108
52-wk High
$1.87
52-wk Low
$0.53

Latest Key Developments (Source: Significant Developments)

Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.QTRLY LOSS PER SHARE $0.91.Q3 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S.CYCLACEL PHARMACEUTICALS - ESTIMATE THAT CASH RESOURCES WILL BE SUFFICIENT TO FUND OPERATIONS UNTIL Q2 OF 2020.  Full Article

Cyclacel Pharmaceuticals Says Entered Into A Common Stock Sales With H.C. Wainwright & Co, In Connection With An At Market Offering
Thursday, 4 Oct 2018 

Oct 4 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS - ENTERED INTO A COMMON STOCK SALES WITH H.C. WAINWRIGHT & CO, IN CONNECTION WITH AN AT MARKET OFFERING - SEC FILING.CYCLACEL PHARMACEUTICALS INC - AS PER ATM OFFERING, CO MAY OFFER AND SELL SHARES, PAR VALUE $0.001 PER SHARE, HAVING OFFERING PRICE OF UP TO $5 MILLION.  Full Article

Cyclacel Pharma Projects Cash Resources To Fund Currently Planned Programs Through End Of 2019
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS INC - CO PROJECTS CASH RESOURCES TO FUND CURRENTLY PLANNED PROGRAMS THROUGH END OF 2019.  Full Article

Cyclacel Pharmaceuticals Q3 loss per share $0.91 including items
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::Cyclacel Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.91 including items.  Full Article